Refinement of a pharmacogenomics app for dosing guidelines for oncology: findings from the usability evaluation

BACKGROUND: This study extended a precision medicine clinical decision support mobile application (app) for use with oncology medications. Two gene variants (CYP2D6 and DPYD) associated with pharmacogenomic dosing algorithms in oncology was added to a prototype app. Usability of the app was evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Dodson, Crystal, Layman, Lucas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816840/
https://www.ncbi.nlm.nih.gov/pubmed/36618784
http://dx.doi.org/10.21037/atm-2022-68

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816840/
https://www.ncbi.nlm.nih.gov/pubmed/36618784
http://dx.doi.org/10.21037/atm-2022-68

Ejemplares similares